Global Thyroid Gland Disorder Treatment Market Report, History and Forecast 2014-2025, Breakdown Data by Companies, Key Regions, Types and Application

Summary

Hormones released by thyroid gland play a crucial role in stimulating metabolism, growth, and calories processing. Globally, thyroid gland disorders such as hypothyroidism, hyperthyroidism, and thyroid nodules affect around 5% to 10% of the population. Hyperthyroidism and hypothyroidism affect majority of the population primarily due to growing incidence of autoimmune diseases such as Grave’s disease and Hashimoto's thyroiditis. Moreover, iodine deficiency is a widespread problem across the globe and is measured as a prime risk factor for the increase in prevalence of thyroid disorders.
The major factors that drive the growth of the market include increase in the incidence of thyroid gland disorder, rise in the number of disease awareness programs especially in the developing countries, and development of effective combination drug therapies to treat thyroid gland disorder. However, side effects of the drugs and stringent government regulations hamper the market growth. Moreover, availability of large pool of undiagnosed patients due to asymptomatic nature of thyroid disorders help open new avenues for the market growth during the forecast period.
One of the primary drivers for the market growth is the escalating patient population with iodine deficiency. Iodine deficiency is predominant around the globe when compared with the large consumers of iodine and is particularly seen in pregnant women and young children. Iodine is present in the body in minute amounts, mainly in the thyroid gland and has a significant role to play in the thyroid synthesis.  It has been observed that over two billion individuals have insufficient iodine intake, among which South Asia and sub-Saharan Africa are majorly affected. The introduction of various remedies for the treatment of this deficiency will boost market growth in the coming years.
In 2018, the global Thyroid Gland Disorder Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% between 2019 and 2025.

This report studies the Thyroid Gland Disorder Treatment market size by players, regions, product types and end industries, history data 2014-2018 and forecast data 2019-2025; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

This report focuses on the global top players, covered
Abbott
bioMérieux
Danaher
DiaSorin
Siemens Healthineers
...

Market segment by Regions/Countries, this report covers
North America
Europe
China
Rest of Asia Pacific
Central & South America
Middle East & Africa

Market segment by Type, the product can be split into
Hyperthyroidism
Hypothyroidism
Others

Market segment by Application, the market can be split into
Men
Women

The study objectives of this report are:
To study and forecast the market size of Thyroid Gland Disorder Treatment in global market.
To analyze the global key players, SWOT analysis, value and global market share for top players.
To define, describe and forecast the market by type, end use and region.
To analyze and compare the market status and forecast among global major regions.
To analyze the global key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Thyroid Gland Disorder Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Raw material suppliers
Distributors/traders/wholesalers/suppliers
Regulatory bodies, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade associations and industry bodies
End-use industries

Available Customizations
With the given market data, offers customizations according to the company's specific needs. The following customization options are available for the report:
Further breakdown of Thyroid Gland Disorder Treatment market on basis of the key contributing countries.
Detailed analysis and profiling of additional market players.